Target intelligence / Profile preview

Plasma and extracellular compartment (ECF)

Target
ECF
Molecular classification
Other
01

Overview

The plasma and extracellular compartment (ECF) represents the total fluid volume of the body located outside of the intracellular environment, consisting primarily of the intravascular plasma and the interstitial fluid that bathes tissues [1]. It serves as the essential medium for the transport of oxygen, nutrients, and hormones to cells and the removal of metabolic waste products to excretory organs [2]. While not a discrete molecular target such as a receptor or enzyme, it is the functional site for various therapeutic interventions aimed at managing fluid dynamics, such as the use of osmotic diuretics like mannitol to reduce intracranial pressure or plasma expanders like albumin to treat hypovolemic shock [3]. Maintaining the integrity and chemical composition of this compartment is critical for systemic homeostasis, and its dysfunction is a hallmark of clinical conditions such as sepsis, renal failure, and congestive heart failure [1,4]. Pharmacologically, this compartment is defined by its volume of distribution and the movement of solutes across semi-permeable membranes [2]. (Sources: [1] StatPearls, Physiology, Extracellular Fluid; [2] StatPearls, Physiology, Plasma; [3] NIH, PubChem, Mannitol; [4] Merck Manual, Overview of Fluid and Electrolyte Balance).

Other names
Extracellular fluidExtracellular spaceIntravascular and interstitial compartmentsPlasmaExtracellular matrix fluid
02

Mechanism of action

Drugs targeting this compartment typically act through osmotic pressure modulation, volume expansion, or electrolyte replenishment to restore systemic fluid balance and tissue perfusion.

03

Biological functions

Fluid homeostasisElectrolyte balanceNutrient transportWaste removalpH bufferingHemodynamic stability
04

Disease associations

EdemaDehydrationShockElectrolyte imbalanceAcidosisAlkalosisHypovolemiaHypervolemia
05

Safety considerations

Fluid overloadCongestive heart failure exacerbationPulmonary edemaElectrolyte derangementOsmotic demyelination syndromeAcute kidney injury (with certain colloids)
06

Interacting drugs

Mannitol

6 more in the full profile.

07

Biomarkers

Serum osmolaritySerum electrolytes (Sodium, Potassium, Chloride, Bicarbonate)HematocritBlood urea nitrogen (BUN)Central venous pressurePlasma oncotic pressure

Beyond the preview

Go deeper on Plasma and extracellular compartment (ECF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasma and extracellular compartment (ECF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call